What guidance did Apyx Medical's management provide for the next earnings period?

What is Apyx Medical's latest dividend and current dividend yield?

What does Apyx Medical do and what are its main business segments?

What is the market's earnings forecast for Apyx Medical next quarter?

What is the revenue and EPS growth rate for Apyx Medical year over year?

Did Apyx Medical beat or miss consensus estimates last quarter?

What is Apyx Medical's gross profit margin?

What factors drove the changes in Apyx Medical's revenue and profit?

Focus on AYON adoption rates, Surgical Aesthetics guidance, and cash flow management.

The company reported Q3 2025 revenue of $12.9 million, up 12% YoY driven by AYON system adoption. Surgical Aesthetics segment revenue reached $11.1 million, with AYON handpiece sales leading the way. CFO noted Q4 guidance of $43-45 million for Surgical Aesthetics. AYON adoption is accelerating with KOLs highlighting its integration into clinical workflows. The company is prioritizing U.S. installations ahead of international expansion in 2026. Key metrics: Q3 GAAP net loss of $2.8 million, with focus on cash management and cost control. Investors should monitor AYON's attach rates and pipeline visibility into Q4. The company reaffirmed 2025 Surgical Aesthetics guidance of $43-45 million, with AYON adoption in the U.S. to drive Q4. International expansion in 2026.

Apyx Medical Corporation (APYX) Q3 2025 Earnings Call Transcript

Revenue

Sales and Services Revenue

Financing Services Revenue

Other Revenue

Cost of Revenue

Cost of Goods and Services

Cost of Financing Services

Other Cost

Gross Profit

Other Operating Income

Operating Expenses

Selling, General and Administrative Expenses

Selling and Marketing Expenses

General and Administrative Expenses

Research and Development Expenses

Loss on Bad Debts

Loss on Impairment of Other Assets

Loss on Disposal of Assets

Other Operating Expenses

Operating Income

Non-Operating Income (Loss)

Income (Loss) from Affiliates

Income (Loss) from Associates

Income (Loss) from Joint ventures

Gain (Loss) on Other Investment

Gain (Loss) on Change in Fair Value

Gain (Loss) on Foreign Currency Exchange

Other Non-Operating Income (Loss)

Net Interest Expense

Interest Expense

Interest Income

Pretax Income From Continuing Operations

Income Tax Expense

Current Income Tax

Deferred Income Tax

Income Tax Adjustments

Net Income from Continuing Operations

Income from Discontinued Operations

Other Items Before Net Income

Net Income

Net Income Attributable to Minority Interests

Net Income Attributable to Owners of the Company

Preferred Stock Dividends

Other Adjustments

Net Income Attributable to Common Stockholders

Other Comprehensive Income

Total Comprehensive Income

Total Comprehensive Income Attributable to Minority Interests

Total Comprehensive Income Attributable to Owners of the Company

Basic EPS

Basic EPS from Continuing Operations

Basic EPS from Discontinued Operations

Diluted EPS

Diluted EPS from Continuing Operations

Diluted EPS from Discontinued Operations

APYX

APYX fundamentals

You can ask Aime